William J. Newell
2018
In 2018, William J. Newell earned a total compensation of $8.7M as Chief Executive Officer at SUTRO BIOPHARMA, a 1,136% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $301,250 |
---|---|
Option Awards | $6,764,993 |
Salary | $482,000 |
Stock Awards | $1,136,355 |
Total | $8,684,598 |
Newell received $6.8M in option awards, accounting for 78% of the total pay in 2018.
Newell also received $301.3K in non-equity incentive plan, $482K in salary and $1.1M in stock awards.
Rankings
In 2018, William J. Newell's compensation ranked 905th out of 14,244 executives tracked by ExecPay. In other words, Newell earned more than 93.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 905 | 94th |
Manufacturing | 302 | 95th |
Chemicals And Allied Products | 91 | 96th |
Drugs | 70 | 96th |
Biological Products, Except Diagnostic Substances | 20 | 94th |
Newell's colleagues
We found two more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2018.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019